- Home
- CLLS vs AGCC Comparison
CLLS vs AGCC Comparison
Compare CLLS & AGCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | AGCC |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | France | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.3M | 419.3M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLLS | AGCC |
|---|---|---|
| Price | $3.91 | $18.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | 26.7K | ★ 136.7K |
| Earning Date | 05-08-2026 | 05-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.98 | N/A |
| P/E Ratio | ★ N/A | $168.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $4.23 |
| 52 Week High | $5.48 | $25.73 |
Technical Indicators
Market Signals| Indicator | CLLS | AGCC |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 52.28 |
| Support Level | $3.39 | $13.33 |
| Resistance Level | $3.83 | $18.11 |
| Average True Range (ATR) | 0.17 | 3.32 |
| MACD | -0.03 | -0.20 |
| Stochastic Oscillator | 7.38 | 38.19 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares
Agencia Comercial Spirits Ltd specializes in the procurement, distribution, and sale of high-quality whiskies, including both bottled and cask whisky in both Taiwan and international markets. The company's product portfolio includes the distribution of bottled whisky, raw cask whisky, and proprietary brand whisky.